The right-to-try legislation guaranteeing that the FDA cannot deny patients the right to try experimental drugs was both championed and criticized by many groups. The conservative/... read more
The right-to-try legislation guaranteeing that the FDA cannot deny patients the right to try experimental drugs was both championed and criticized by many groups. The conservative/... read more
Peloton Therapeutics, Inc., announced on 6/6/2018 the dosing of the first patient in a Phase 2 trial evaluating the efficacy and safety of lead investigational oncology agent, PT2977, to treat von... read more
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) (“BioCryst” or the “Company”), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, today issued... read more
